ANVISA registration

FAMÍLIA MAGLUMI Anti HBc IgM (CLIA)

Registration 80102512962. IMUNOGLOBULINA M NUCLEAR PARA VÍRUS DE HEPATITE B (ANTI-HBC IGM)

Registration details

Registration number80102512962
Application number25351305791202226
Technical nameIMUNOGLOBULINA M NUCLEAR PARA VÍRUS DE HEPATITE B (ANTI-HBC IGM)
Risk classIV
Published on22/02/2023
ValidityValid until 22/02/2033

Registration holder

Legal nameVR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA
CNPJ04.718.143/0001-94

Manufacturer

  • SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. CHINA, REPÚBLICA POPULAR

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist